AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $700,000 | +131.8% | 92,389 | +69.2% | 0.05% | +168.4% |
| Q4 2018 | $302,000 | -15.6% | 54,593 | +52.4% | 0.02% | -24.0% |
| Q2 2018 | $358,000 | +14.0% | 35,822 | +69.8% | 0.02% | -26.5% |
| Q4 2017 | $314,000 | -9.2% | 21,102 | +19.9% | 0.03% | -60.9% |
| Q3 2017 | $346,000 | +119.0% | 17,606 | +2.2% | 0.09% | +335.0% |
| Q1 2017 | $158,000 | -54.1% | 17,220 | -47.9% | 0.02% | -63.0% |
| Q4 2016 | $344,000 | +41.6% | 33,034 | +1.8% | 0.05% | +68.8% |
| Q2 2016 | $243,000 | -57.4% | 32,442 | -26.6% | 0.03% | -36.0% |
| Q4 2015 | $571,000 | -18.4% | 44,200 | -39.0% | 0.05% | -16.7% |
| Q3 2015 | $700,000 | – | 72,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |